000			02451 a2200757 4500
005			20250516145604.0
264		0	_c20141006
008			201410s 0 0 eng d
022			_a1433-8726
024	7		_a10.1007/s00345-013-1088-1 _2doi
040			_aNLM _beng _cNLM
100	1		_aBigot, Pierre
245	0	0	_aNeoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful? _h[electronic resource]
260			_bWorld journal of urology _cFeb 2014
300			_a109-14 p. _bdigital
500			_aPublication Type: Journal Article; Multicenter Study
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aCarcinoma, Renal Cell _xepidemiology
650	0	4	_aCombined Modality Therapy
650	0	4	_aComorbidity
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aFrance
650	0	4	_aHumans
650	0	4	_aIndoles _xtherapeutic use
650	0	4	_aKidney Neoplasms _xepidemiology
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aNeoadjuvant Therapy
650	0	4	_aNephrectomy
650	0	4	_aNiacinamide _xanalogs & derivatives
650	0	4	_aPhenylurea Compounds _xtherapeutic use
650	0	4	_aPyrroles _xtherapeutic use
650	0	4	_aRetrospective Studies
650	0	4	_aSorafenib
650	0	4	_aSunitinib
650	0	4	_aThrombectomy
650	0	4	_aThrombosis _xepidemiology
650	0	4	_aTreatment Outcome
650	0	4	_aVena Cava, Inferior _xsurgery
700	1		_aFardoun, Tarek
700	1		_aBernhard, Jean Christophe
700	1		_aXylinas, Evanguelos
700	1		_aBerger, Julien
700	1		_aRouprêt, Morgan
700	1		_aBeauval, Jean-Baptiste
700	1		_aLagabrielle, Samuel
700	1		_aLebdai, Souhil
700	1		_aAmmi, Myriam
700	1		_aBaumert, Hervé
700	1		_aEscudier, Bernard
700	1		_aGrenier, Nicolas
700	1		_aHétet, Jean-François
700	1		_aLong, Jean-Alexandre
700	1		_aPaparel, Philippe
700	1		_aRioux-Leclercq, Nathalie
700	1		_aSoulié, Michel
700	1		_aAzzouzi, Abdel-Rahmène
700	1		_aBensalah, Karim
700	1		_aPatard, Jean-Jacques
773	0		_tWorld journal of urology _gvol. 32 _gno. 1 _gp. 109-14
856	4	0	_uhttps://doi.org/10.1007/s00345-013-1088-1 _zAvailable from publisher's website
999			_c22706483 _d22706483